Does the anti-prothrombin antibodies measurement provide additional information in patients with thrombosis?

Immunobiology

Volumn 212, Issue 7, 2007, Pages 557-565

  Bardin, Nathalie ^a,b   Alessi, Marie Christine ^c   Dignat George, Francoise ^a,b   Vague, Irene Juhan ^c   Sampol, Jose ^a,b   Harlé, Jean Robert ^a   Sanmarco, Marielle ^a  

^a HÔPITAL DE LA CONCEPTION   (France)

^b INSERM   (France)

^c TIMONE HOSPITAL   (France)

Author keywords

Anti prothrombin antibodies; Antiphospholipid antibodies; IgG aPS PT; IgG aPT; IgG a 2< inf>GPI; Thrombosis

Indexed keywords

ANTITHROMBIN; BETA2 GLYCOPROTEIN 1 ANTIBODY; BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; PHOSPHATIDYLSERINE; PROTEIN C; PROTEIN S; PROTHROMBIN; PROTHROMBIN ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTERY THROMBOSIS; ARTICLE; BINDING AFFINITY; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; VEIN THROMBOSIS;

EID: 34547210670     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2007.02.001     Document Type: Article

References (34)

1. Akimoto T., Akama T., Kono I., Yamane K., and Sumida T. Detergent and antigen fragility affect the ELISA for measurement of anti-prothrombin autoantibodies. J. Rheumatol. 26 (1999) 580-587
2. Akimoto T., Akama T., Saitoh M., Kono I., and Sumida T. Antiprothrombin autoantibodies in severe preeclampsia and abortion. Am. J. Med. 110 (2001) 188-191
3. Arvieux J., Darnige L., Caron C., Reber G., Bensa J.C., and Colomb M.G. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb. Haemost. 74 (1995) 1120-1125
4. Atsumi T., Ieko M., Bertolaccini M.L., Ichikawa K., Tsutsumi A., and Matsuura E. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum. 43 (2000) 1982-1993
5. Atsumi T., Amengual O., Yasuda S., and Koike T. Antiprothrombin antibodies - are they worth assaying?. Thromb Res. 114 (2004) 533-538
6. Barcat D., Constans J., and Guerin V. Anti-prothrombin autoantibodies and portal vein thrombosis without antiphospholipid antibodies. J. Rheumatol. 26 (1999) 1007-1008
7. Bertolaccini M.L., Atsumi T., Khamashta M.A., Amengual O., and Hughes G.R. Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus. J. Rheumatol. 25 (1998) 1104-1108
8. Bertolaccini M.L., Hughes G.R., and Khamashta M.A. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins. Clin. Lab. 50 (2004) 653-665
9. Bertolaccini M.L., Atsumi T., Koike T., Hughes G.R., and Khamashta M.A. Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus. Thromb. Haemost. 93 (2005) 289-297
10. Bevers E.M., Galli M., Barbui T., Comfurius P., and Zwaal R.F. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb. Haemost. 66 (1991) 629-632
11. Brandt J.T., Triplett D.A., Alving B., and Scharrer I. Criteria for the diagnosis of LA: an update. Thromb. Haemost. 74 (1995) 1185-1190
12. Forastiero R., Martinuzzo M., Adamczuk Y., and Carreras L.O. Occurrence of anti-prothrombin and anti-beta2-glycoprotein I antibodies in patients with history of thrombosis. J. Lab. Clin. Med. 134 (1999) 610-615
13. Galli M., and Barbui T. Prothrombin as cofactor for antiphospholipids. Lupus 7 Suppl. 2 (1998) S37-S40
14. Galli M., Beretta G., Daldossi M., Bevers E.M., and Barbui T. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies. Thromb. Haemost. 77 (1997) 486-491
15. Galli M., Luciani D., Bertolini G., and Barbui T. Anti-beta 2-glycoprotein I, anti-prothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood 102 (2003) 2717-2723
16. Haj-Yahia S., Sherer Y., Blank M., Kaetsu H., Smolinsky A., and Shoenfeld Y. Anti-prothrombin antibodies cause thrombosis in a novel qualitative ex-vivo animal model. Lupus 12 (2003) 364-369
17. Horbach D.A., van Oort E., Donders R.C., Derksen R.H., and de Groot P.G. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies. Thromb. Haemost. 76 (1996) 916-924
18. Koskenmies S., Vaarala O., Widen E., Kere J., Palosuo T., and Julkunen H. The association of antibodies to cardiolipin, beta 2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus. Scand. J. Rheumatol. 33 (2004) 246-252
19. Loeliger A. Prothrombin as a co-factor of the circulating anticoagulant in systemic lupus erythematosus?. Thromb. Diath. Haemorrh. 3 (1959) 237-256
20. Luzzana C., Gerosa M., Riboldi P., and Meroni P.L. Up-date on the antiphospholipid syndrome. J. Nephrol. 15 (2002) 342-348
21. Matsuda J., Sanaka T., Nishizawa A., Gotoh M., and Gohchi K. Two anti-prothrombin antibodies against prothrombin and prothrombin-phosphatidyl serine show partial but not total identity. Blood Coagul. Fibrin. 13 (2002) 697-702
22. Micheloud D., Sanchez-Ramon S., Carbone J., Rodriguez Molina J.J., Fernandez-Cruz E., Lopez-Longo F.J., and Rodriguez-Mahou M. Discordance between anti-beta2-glycoprotein-I and anti-cardiolipin antibodies in patients with clinical criteria of antiphospholipid syndrome. Clin. Exp. Rheumatol. 23 (2005) 525-528
23. Miyakis S., Lockishin M., Atsumi T., Branch D., Brey R.L., Cervera R., Derksen R.H., de Groot P.G., Koike T., Meroni P.L., Reber G., Schoenfeld Y., Tincani A., Vlachoyiannopoulos P.G., and Krilis S.A. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 4 (2005) 295-306
24. Pengo V., Biasiolo A., Brocco T., Tonetto S., and Ruffatti A. Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies. Thromb. Haemost. 75 (1996) 721-724
25. Roubey R.A. Immunology of the antiphospholipid syndrome: antibodies, antigens, and autoimmune response. Thromb. Haemost. 82 (1999) 656-661
26. Sanmarco M., Soler C., Christides C., Raoult D., Weiller P.J., Gerolami V., and Bernard D. Prevalence and clinical significance of IgG isotype anti-beta 2-glycoprotein I antibodies in antiphospholipid syndrome: a comparative study with anticardiolipin antibodies. J. Lab. Clin. Med. 129 (1997) 499-506
27. Simmelink M.J., Horbach D.A., Derksen R.H., Meijers J.C., Bevers E.M., Willems G.M., and de Groot P.G. Complexes of anti-prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfaces. Br. J. Haematol. 113 (2001) 621-629
28. Tincani A., Allegri F., Sanmarco M., Cinquini M., Taglietti M., Balestrieri G., Koike T., Ichikawa K., Meroni P., and Boffa M.C. Anticardiolipin antibody assay: a methodological analysis for a better consensus routine determinations - a cooperative project of the European Antiphospholipid Forum. Thromb. Haemost. 86 (2001) 575-583
29. Tsutsumi A., Atsumi T., Yamada H., Hirayama, Kato E., Ichikawa K., Fujimoto S., and Koike T. Antiphosphatidylserine/prothrombin antibodies are not frequently found in patients with unexplained recurrent miscarriages. Am. J. Reprod. Immunol. 46 (2001) 242-244
30. Vaarala O., Puurunen M., Manttari M., Manninen V., Aho K., and Palosuo T. Antibodies to prothrombin imply a risk of myocardial infarction in middle-aged men. Thromb. Haemost. 75 (1996) 456-459
31. von Landenberg P., Matthias T., Zaech J., Schultz M., Lorber M., Blank M., and Shoenfeld Y. Antiprothrombin antibodies are associated with pregnancy loss in patients with the antiphospholipid syndrome. Am. J. Reprod. Immunol. 49 (2003) 51-56
32. Wahl D.G., Guillemin F., de Maistre E., Perret C., Lecompte T., and Thibaut G. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus - a meta-analysis. Lupus 6 (1997) 467-473
33. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C., Brey R., Derksen R., Harris E.N., Hughes G.R., Triplett D.A., and Khamashta M.A. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 2 (1999) 1309-1311
34. Zanon E., Saggiorato G., Ramon R., Girolami A., Pagnan A., and Prandoni P. Anti-prothrombin antibodies as a potential risk factor of recurrent venous thromboembolism. Thromb. Haemost. 91 (2004) 255-258